Cost-Effectiveness Analysis of Treating Acute Promyelocytic Leukemia Patients with Arsenic Trioxide and Retinoic Acid in the United States

INTRODUCTION: This study estimated the cost-effectiveness of arsenic trioxide (ATO) added to all-trans retinoic acid (ATRA) when used in first-line acute promyelocytic leukemia (APL) treatment. METHODS: A Markov cohort model was developed with three states: stable disease (during first- or second-li...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Clin Lymphoma Myeloma Leuk
Autors principals: Tallman, Martin, Lo-Coco, Francesco, Barnes, Gisoo, Kruse, Morgan, Wildner, Rebecca, Martin, Monique, Udo Mueller, U, Tang, Boxiong
Format: Artigo
Idioma:Inglês
Publicat: 2015
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5028894/
https://ncbi.nlm.nih.gov/pubmed/26361645
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.clml.2015.07.634
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars